Deals

The Italian firm Angelini Pharma is buying Catalyst Pharmaceuticals, the maker of rare disease drugs, for $4.1…

Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana…

Knoa Pharma will still sell the opioid medications that triggered a national crisis, but with guardrails.…

Madrigal Pharmaceuticals has struck a backloaded deal for the global license to an Arrowhead Pharmaceuticals p…

MSD has completed its acquisition of Terns Pharmaceuticals, expanding its pipeline of treatments for chronic m…

UCB has struck a deal to acquire Candid Therapeutics for $2 billion upfront, hijacking a planned reverse merge…